No. | Gender | Age (yrs) | Symptoms | Diameter (cm) | Pathology diagnose | Operation | Status |
---|---|---|---|---|---|---|---|
1 | Male | 59 | Chest pain | 5 | Basaloid carcinoma | Y | Stable |
2 | Male | 51 | Back pain | 7.4 | Squamous-cell carcinoma | Y | Dead |
3 | Female | 46 | Back pain | 5.5 | Squamous-cell carcinoma | Y | Stable |
4 | Male | 55 | Chest pain | 3.7 | Atypical carcinoid | Y | Stable |
5 | Male | 40 | Asymptomatic | 7 | Atypical carcinoid | Y | Stable |
6 | Female | 47 | Myasthenia gravis | 7 | Squamous-cell carcinoma | Y | Stable |
7 | Male | 34 | Chest distress | 5.5 | Squamous-cell carcinoma | Y | Stable |
8 | Male | 43 | Superior vena cava syndrome | 5 | Atypical carcinoid | Y | Dead |
9 | Female | 52 | Myasthenia gravis | 6 | Squamous-cell carcinoma | Y | Stable |
10 | Male | 23 | Superior vena cava syndrome | 7.2 | Undifferentiated carcinoma | Y | Dead |
11 | Male | 26 | Hypokalemia | 5 | Undifferentiated carcinoma | Y | Dead |
12 | Female | 52 | Asymptomatic | 5 | Squamous-cell carcinoma | Y | Stable |
13 | Male | 53 | Chest pain | 12.7 | Squamous-cell carcinoma | N | Dead |
14 | Male | 65 | Myasthenia gravis | 5.8 | Squamous-cell carcinoma | N | Dead |
15 | Male | 46 | Asymptomatic | 4.2 | Undifferentiated carcinoma | N | Dead |
16 | Male | 53 | Shoulder Pain | 6.9 | Squamous-cell carcinoma | N | Dead |
17 | Male | 58 | Asymptomatic | 5.8 | Atypical carcinoid | N | Dead |
18 | Female | 62 | Myasthenia gravis | 6 | Squamous-cell carcinoma | N | Stable |
19 | Female | 59 | Asymptomatic | 9.2 | Squamous-cell carcinoma | N | Dead |
20 | Male | 67 | Chest pain | 6 | Undifferentiated carcinoma | N | Dead |
21 | Male | 51 | Chest distress | 16.2 | Squamous-cell carcinoma | N | Stable |
22 | Male | 53 | Superior vena cava syndrome | 5 | Undifferentiated carcinoma | N | Lung metastasis |
23 | Female | 39 | Asymptomatic | 6.6 | Basaloid carcinoma | N | Dead |
24 | Male | 53 | Chest pain | 8.7 | Squamous-cell carcinoma | N | Lung metastasis |
25 | Male | 60 | Chest pain | 9.4 | Squamous-cell carcinoma | N | Dead |
26 | Male | 20 | Myasthenia gravis | 5.5 | Atypical carcinoid | N | Stable |